Could Ventas, Inc. (VTR) Gain Strenght? The Stock Reaches Yearly Low

April 24, 2018 - By Linda Rogers

Ventas, Inc. (NYSE:VTR) Logo

Investors sentiment increased to 1.2 in 2017 Q4. Its up 0.09, from 1.11 in 2017Q3. It improved, as 32 investors sold Ventas, Inc. shares while 195 reduced holdings. 74 funds opened positions while 198 raised stakes. 306.00 million shares or 2.88% less from 315.08 million shares in 2017Q3 were reported.
Eqis Cap Mngmt holds 6,028 shares. Alpine Woods Capital Invsts Ltd Liability Corp owns 73,612 shares. Bennicas And Assoc has 14,861 shares for 0.78% of their portfolio. Great West Life Assurance Company Can has 459,270 shares. Apriem Advisors, a California-based fund reported 6,983 shares. Valley National Advisers Inc holds 275 shares or 0.01% of its portfolio. 105,504 are owned by Decatur Mgmt. Raymond James & holds 1.33M shares or 0.15% of its portfolio. Gemmer Asset Management Ltd stated it has 0.01% of its portfolio in Ventas, Inc. (NYSE:VTR). Argent Company reported 5,297 shares. Webster Financial Bank N A invested 0.04% of its portfolio in Ventas, Inc. (NYSE:VTR). Cap Intl Investors holds 0.28% of its portfolio in Ventas, Inc. (NYSE:VTR) for 4.14M shares. State Of New Jersey Common Pension Fund D stated it has 269,200 shares. Geode Cap Mngmt Limited Liability Company invested in 0.09% or 4.42 million shares. 1,586 are held by Benjamin F Edwards Incorporated.

The stock of Ventas, Inc. (NYSE:VTR) hit a new 52-week low and has $43.04 target or 9.00 % below today’s $47.30 share price. The 6 months bearish chart indicates high risk for the $16.97B company. The 1-year low was reported on Apr, 24 by Barchart.com. If the $43.04 price target is reached, the company will be worth $1.53B less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock.

The stock increased 0.72% or $0.34 during the last trading session, reaching $47.3. About 1.19M shares traded. Ventas, Inc. (NYSE:VTR) has declined 23.52% since April 24, 2017 and is downtrending. It has underperformed by 35.07% the S&P500.

Analysts await Ventas, Inc. (NYSE:VTR) to report earnings on April, 27 before the open. They expect $1.01 earnings per share, down 2.88 % or $0.03 from last year’s $1.04 per share. VTR’s profit will be $362.34 million for 11.71 P/E if the $1.01 EPS becomes a reality. After $1.03 actual earnings per share reported by Ventas, Inc. for the previous quarter, Wall Street now forecasts -1.94 % negative EPS growth.

Ventas, Inc. (NYSE:VTR) Ratings Coverage

Among 12 analysts covering Ventas (NYSE:VTR), 1 have Buy rating, 3 Sell and 8 Hold. Therefore 8% are positive. Ventas had 20 analyst reports since October 30, 2017 according to SRatingsIntel. The rating was maintained by SunTrust with “Hold” on Friday, October 27. The firm earned “Hold” rating on Friday, February 9 by Mizuho. The rating was maintained by Jefferies with “Hold” on Monday, February 12. As per Tuesday, February 13, the company rating was maintained by Citigroup. The firm has “Hold” rating by Wells Fargo given on Tuesday, February 13. The rating was maintained by BMO Capital Markets on Monday, March 26 with “Sell”. The firm has “Hold” rating by Deutsche Bank given on Monday, March 19. As per Monday, January 22, the company rating was maintained by SunTrust. Stifel Nicolaus maintained the shares of VTR in report on Friday, February 9 with “Hold” rating. The stock has “Underperform” rating by Raymond James on Monday, December 4.

Ventas, Inc. is a publicly owned real estate investment trust. The company has market cap of $16.97 billion. The firm engages in investment, management, financing, and leasing of properties in the healthcare industry. It has a 12.51 P/E ratio. It invests in the real estate markets of the United States and Canada.

Ventas, Inc. (NYSE:VTR) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: